Vertex Pharma (VRTX) Granted European CHMP Positive Opinion for KALYDECO for Children/Adolescents with CF and R117H Mutation in CFTR Gene
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Vertex (VRTX) PT Raised to $305 at Citi
May 1, 2020 5:17 AM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $305 at Citi
April 30, 2020 4:12 PM EDTCiti analyst Mohit Bansal raised the price target on Vertex (NASDAQ: VRTX) to $305.00 (from $265.00) while maintaining a Buy rating.
... MoreVertex (VRTX) PT Raised to $277 at Morgan Stanley
April 30, 2020 8:11 AM EDTMorgan Stanley raised its price target on Vertex (NASDAQ: VRTX) to $277.00 (from $258.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $281 at Cantor Fitzgerald
April 30, 2020 6:34 AM EDTCantor Fitzgerald analyst Alethia Young raised the price target on Vertex (NASDAQ: VRTX) to $281.00 (from $275.00) while maintaining a Overweight rating.... More
Vertex (VRTX) PT Raised to $285 at Stifel
April 30, 2020 4:38 AM EDTStifel analyst Paul Matteis raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $275.00) while maintaining a Buy rating.... More
Vertex (VRTX) PT Raised to $285 at JMP Securities
April 30, 2020 4:38 AM EDTJMP Securities analyst Joseph Osha raised the price target on Vertex (NASDAQ: VRTX) to $285.00 (from $255.00) while maintaining a Market Outperform rating.... More
Vertex Pharma (VRTX) Tops Q1 EPS by 72c, Revenues Beat; Raises FY20 Revenues Guidance
April 29, 2020 4:04 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $2.56, $0.72 better than the analyst estimate of $1.84. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.29 billion.
"The COVID-19 pandemic has presented unprecedented challenges to societies, communities and businesses around the world, and while these global challenges will... More
